Established in 2019, we are currently commercially validating our first product, ImmuLUNG™ for inhalation safety assessment which will be launching in 2021. ImmuLUNG™ is a 3D human immunocompetent co-culture model of the alveolus.

We also provide bespoke in-house testing services for inhalation safety assessment using state of the art techniques.

Understanding the interplay between a chemical, biological barrier and immune system is integral to next-generation safety assessment.

Stay up to date with ImmuONE

Login or create a free user account to follow this company and see updates on your dashboard.

Create account